FDA Inspection
Catalent France Beinheim SACatalent France Beinheim SA – FDA Inspection, Jul 21, 2017
Record Details
This FDA Inspection record concerns Catalent France Beinheim SA, with an inspection on July 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · baf85424-4ec9-4766-97c4-c7381d365f2d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022739
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Catalent France Beinheim SA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2022 | VAI | Drug Quality Assurance | |
| October 29, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Catalent France Beinheim SA
- FDA Inspection 1302124 - 2022-11-25
- FDA Inspection 1174733 - 2020-10-29
- FDA Inspection 878382 - 2014-03-20
- FDA Inspection 792665 - 2012-07-13
- FDA Inspection 621606 - 2009-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.